Co-Authors
This is a "connection" page, showing publications co-authored by DIANA BELL and YOKO TAKAHASHI.
Connection Strength
1.104
-
High-grade sinonasal carcinomas and surveillance of differential expression in immune related transcriptome. Ann Diagn Pathol. 2020 Dec; 49:151622.
Score: 0.185
-
Identification of markers predictive for response to induction chemotherapy in patients with sinonasal undifferentiated carcinoma. Oral Oncol. 2019 10; 97:56-61.
Score: 0.172
-
Identification of novel diagnostic markers for sinonasal undifferentiated carcinoma. Head Neck. 2019 08; 41(8):2688-2695.
Score: 0.168
-
Human epidermal growth factor receptor 2/neu as a novel therapeutic target in sinonasal undifferentiated carcinoma. Head Neck. 2016 04; 38 Suppl 1:E1926-34.
Score: 0.134
-
Comprehensive assessment of prognostic markers for sinonasal squamous cell carcinoma. Head Neck. 2014 Aug; 36(8):1094-102.
Score: 0.115
-
Establishment and characterization of novel cell lines from sinonasal undifferentiated carcinoma. Clin Cancer Res. 2012 Nov 15; 18(22):6178-87.
Score: 0.107
-
Brd4::Nutm1 fusion gene initiates NUT carcinoma in vivo. Life Sci Alliance. 2024 Jul; 7(7).
Score: 0.060
-
Targeting sinonasal undifferentiated carcinoma with a combinatory immunotherapy approach. Transl Oncol. 2024 Jun; 44:101943.
Score: 0.059
-
International Multicenter Study of Clinical Outcomes of Sinonasal Melanoma Shows Survival Benefit for Patients Treated with Immune Checkpoint Inhibitors and Potential Improvements to the Current TNM Staging System. J Neurol Surg B Skull Base. 2023 Aug; 84(4):307-319.
Score: 0.053
-
Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma. Eur J Cancer. 2022 02; 162:221-236.
Score: 0.051